Restoring neuroprotection through a new preclinical paradigm: translational success for NA-1 in stroke therapy
基本信息来源于合作网站,原文需代理用户跳转至来源网站获取
摘要:
Cerebrovascular disease remains one of the leading causes of death and disability throughout the world,and with an aging population,prevalence rates are expected to rise dramatically over the coming years[1].It is thus imperative that we develop effective treatment strategies to meet this challenge.Presently,the only established method of pharmacological stroke intervention is early reperfusion by way of thrombolytic agents,yet the narrow therapeutic window and high risk of complications associated with these drugs disqualify most patients from receiving them.